Clinical Trial Update: Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating the safety and tolerability of TNG462 in MTAP-deleted solid tumors, with recruitment ongoing for locally advanced solid tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• TNG462

Snippet

Sponsor: Tango Therapeutics, Inc. | Conditions: Locally Advanced Solid Tumor | Phase 1, Phase 2 | Status: RECRUITING